FEOC
UFLPA Entity ListCriticalEntity

Nanjing Lilai Pharmaceutical Technology Co., Ltd.

🇨🇳ChinaCovered NationAdded 2026-08-03Nanjing Lilai Pharmaceutical Technology Co., Ltd.

FEOC Flagged

Nanjing Lilai Pharmaceutical Technology Co., Ltd. appears on 2 critical federal lists. Equipment, services, or transactions involving this entity likely fail FEOC requirements for IRA tax credits (45X, 48E, 30D).

Critical findings

  • UFLPA Entity List — Entities using forced labor from Xinjiang. Goods are presumptively excluded from U.S. import per the Uyghur Forced Labor Prevention Act.
  • OFAC SDN — Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.

Covered nation: The IRA defines China, Russia, Iran, and North Korea as covered nations. Entities operating from these jurisdictions face heightened FEOC scrutiny independent of specific list designations.

Risk Summary
List severityHighOn 2 critical lists
Country riskHighChina (covered nation)
Ownership transparencyHighNot in global LEI registry — opacity flag
Parent exposureMediumNo parent data
Cross-list countMedium2 federal lists

Relationships at a glance

3 nodes · 2 relationships · open Network tab for full view
Federal list
UFLPA Entity List2026
DHS / FLETF
Federal list
OFAC SDN
Treasury OFAC
This entity
Nanjing Lilai Pharmaceutical Technology Co., Ltd.Covered
China

Federal-list cross-reference

This entity name appears on 2 federal lists.

UFLPA Entity ListDHS / FLETF

Entities using forced labor from Xinjiang. Goods are presumptively excluded from U.S. import per the Uyghur Forced Labor Prevention Act.

Listed as: Nanjing Lilai Pharmaceutical Technology Co., Ltd.Since 2026-08-03#Nanjing Lilai Pharmaceutical Technology Co., Ltd.
Official list
OFAC SDNTreasury OFAC

Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.

Listed as: HANHONG PHARMACEUTICAL TECHNOLOGY CO., LTD.#45379
Official list

Relationship graph

3 nodes · 2 relationships
Federal list
UFLPA Entity List2026
DHS / FLETF
Federal list
OFAC SDN
Treasury OFAC
This entity
Nanjing Lilai Pharmaceutical Technology Co., Ltd.Covered
China

Click any node to open its source. Federal lists at top, primary entity in center, parents and curated profile below.

Sanctions programs / authorities

UFLPA

Data sources

  • UFLPA Entity List · DHS / FLETF · listed 2026-08-03source
  • OFAC SDN · Treasury OFACsource
Raw record (for audit / legal review)
{
  "source_list": "UFLPA",
  "source_record_id": "Nanjing Lilai Pharmaceutical Technology Co., Ltd.",
  "source_url": "https://www.dhs.gov/uflpa-entity-list",
  "citation": "UFLPA Entity List (DHS/FLETF), effective August 3, 2026",
  "entity_name": "Nanjing Lilai Pharmaceutical Technology Co., Ltd.",
  "entity_type": "Entity",
  "country": "China",
  "aliases": [],
  "addresses": [],
  "programs": [
    "UFLPA"
  ],
  "date_added": "2026-08-03",
  "raw_data": {
    "uflpa_sublist": 2,
    "effective_date": "August 3, 2026"
  }
}

Informational only — not legal advice. Cross-list matching is name-based; verify identity with the source authority before procurement or compliance decisions.